Analyst Stock Ratings: Calix, Inc. (CALX), Nucor Corporation (NUE)

Calix, Inc. (NYSE:CALX) tinted gains of +1.49% (+0.16 points) to US$10.88. The volume of 0.28 Million shares climbed down over an trading activity of 479.26 Million shares. EPS ratio determined by looking at last 12 month figures is -2.18. Over the same time span, the stock marked US$11.2 as its best level and the lowest price reached was US$6. The corporation has a market cap of US$559.23 Million.

Calix, Inc. (NYSE:CALX)’s earnings per share has been growing at a -41.5 percent rate over the past 5 year when average revenue increase was noted as 9.1 percent. The return on equity ratio or ROE stands at -18.7 percent while most common profitability ratio return on investment (ROI) was -95.5 percent. The company’s institutional ownership is monitored at 63.1 percent. The company’s net profit margin has achieved the current level of -5.7 percent and possesses 42.3 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 1 think it is Hold. Recently, analysts have updated the overall rating to 2. 2 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

Nucor Corporation (NYSE:NUE) is worth US$19.35 Billion and has recently risen 1.49% to US$61.24. The latest exchange of 4.41 Million shares is above its average trading activity of 2.58 Million shares. The day began at US$59.74 but the price moved to US$58.9 at one point during the trading and finally capitulating to a session high of US$61.56. The stock tapped a 52-week high of US$69.79 while the mean 12-month price target for the shares is US$70.43.

Currently, the stock carries a price to earnings ratio of 10.16, a price to book ratio of 1.98, and a price to sales ratio of 0.81. For the past 5 years, the company’s revenue has grown 0.8%, while the company’s earnings per share has grown 17.6%. With an institutional ownership near 79.9%, it carries an earnings per share ratio of 6.03.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 5 brokerage firms polled by Factset Research. At present, 4 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 6 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.93.